Mitja Kos
- Geriatrics and Gerontology top 0.5%
- Pharmaceutical Practices and Patient Outcomes 22
- Family Practice top 1%
- Medication Adherence and Compliance 14
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life 24
- Pharmaceutical Economics and Policy 15
- Toxicology top 10%
-
- Pharmaceutical studies and practices 9
-
- Diabetes Treatment and Management 7
- Diabetes Management and Research 4
-
- Blood Pressure and Hypertension Studies 4
Mitja Kos
79 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 117
- Geriatrics and Gerontology 474
- Family Practice 191
- Applied Microbiology and Biotechnology 46
- Economics and Econometrics 313
- Toxicology 33
Countries citing papers authored by Mitja Kos
This map shows the geographic impact of Mitja Kos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitja Kos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitja Kos more than expected).
Fields of papers citing papers by Mitja Kos
This network shows the impact of papers produced by Mitja Kos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitja Kos. The network helps show where Mitja Kos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mitja Kos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2020 | 8 | |
| 6 | 2020 | 23 | |
| 7 | 2019 | 27 | |
| 8 | 2018 | 5 | |
| 9 | 2018 | 166 | |
| 10 | 2017 | 5 | |
| 11 | 2017 | 40 | |
| 12 | 2017 | 1 | |
| 13 | 2017 | 54 | |
| 14 | 2015 | 4 | |
| 15 | 2014 | 15 | |
| 16 | 2011 | 14 | |
| 17 | 2007 | 1 | |
| 18 | 2005 | 2 | |
| 19 | 2001 | 0 | |
| 20 | 1986 | 10 |
About Mitja Kos
Mitja Kos is a scholar working on Geriatrics and Gerontology, Family Practice and Toxicology, having authored 84 papers that have together received 1.2k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (24 papers), Pharmaceutical Practices and Patient Outcomes (22 papers), Pharmaceutical Economics and Policy (15 papers), Medication Adherence and Compliance (14 papers), Pharmaceutical studies and practices (9 papers), Diabetes Treatment and Management (7 papers), Diabetes Management and Research (4 papers) and Blood Pressure and Hypertension Studies (4 papers). The work is most often cited by research in Geriatrics and Gerontology (474 citations), Family Practice (191 citations) and Applied Microbiology and Biotechnology (46 citations). Mitja Kos has collaborated with scholars based in Slovenia, Croatia and Portugal. Frequent co-authors include Nejc Horvat, Igor Locatelli, Aleš Mrhar, Kurt E. Hersberger, M Obradović, J. W. Foppe van Mil, Markus Messerli, Nina Griese‐Mammen, Saija Leikola and Rose Anne Kenny. Their work appears in journals such as International Journal of Clinical Pharmacy, Acta Pharmaceutica, PLoS ONE, Research in Social and Administrative Pharmacy and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.